백혈구 성분채집술 시장 규모, 점유율, 성장 분석, 유형별, 용도별, 최종 사용자별, 지역별 - 산업별 예측(2024-2031년)
Leukapheresis Market Size, Share, Growth Analysis, By Type (Disposables, Devices), By Application (Research Applications, Therapeutic Applications), By End User, By Region - Industry Forecast 2024-2031
상품코드:1619268
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
백혈구 성분채집술 세계 시장 규모는 2022년 6,630만 달러로 평가되었고, 2023년 7,187만 달러에서 2031년에는 1억 3,702만 달러로 성장할 것으로 예상되며, 예측 기간(2024-2031년) 동안 8.40%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.
세계의 백혈구 성분채집술 시장은 혈액 질환 및 자가 면역 질환 증가로 인해 크게 성장하고 있습니다. 백혈구를 선택적으로 분리하는 이 과정은 진단 방법을 발전시키는 동시에 백혈병 및 자가면역질환과 같은 질환의 치료에 중요한 역할을 하고 있습니다. 백혈구 제거 치료 시스템의 기술 혁신은 시술의 효과와 안전성을 향상시켜 신뢰할 수 있는 치료 옵션으로서의 매력을 높이고 있습니다. 그러나 필요한 장비와 숙련된 인력에 대한 인식 부족과 높은 비용으로 인해 시장 성장에 걸림돌이 될 수 있습니다. 특히 백혈구 성분채집술과 개인 맞춤형 의료, CAR-T 세포 치료와 같은 세포 기반 치료가 교차하는 분야는 치료 기회가 풍부합니다. 헬스케어 인프라가 발전함에 따라 연구와 비용 효율적인 솔루션에 대한 투자로 이 중요한 시장 분야는 더욱 확대될 수 있습니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter's Five Forces 분석과 영향
경쟁 기업간 경쟁 관계
대체품의 위협
바이어의 교섭력
신규 진출업체의 위협
공급 기업의 교섭력
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2023년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
기술 진보
규제 상황
사례 연구
백혈구 성분채집술 시장 규모 : 유형별
시장 개요
일회용
장비
원심분리 장비
막분리 장비
백혈구 성분채집술 시장 규모 : 용도별
시장 개요
연구 용도
치료 용도
백혈구 성분채집술 시장 규모 : 최종사용자별
시장 개요
혈액 성분 공급업체 및 혈액 센터
학술연구기관
제약 기업 및 바이오테크놀러지 기업
병원과 수혈 센터
백혈구 성분채집술 시장 규모 : 지역별
북미
미국
캐나다
유럽
영국
독일
스페인
프랑스
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채택한 전략
시장 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업 개요
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출 전년대비 비교(2021-2023년)
주요 기업 개요
Terumo BCT
Fresenius SE & Co. KGaA
Haemonetics Corporation
Asahi Kasei Corporation
Macopharma SA
Miltenyi Biotec
Medica Spa
Puriblood Medical Co. Ltd.
Beijing ZKSK Technology Co. Ltd.
SB-Kawasumi Laboratories, Inc.
Nikkiso Co., Ltd.
Charles River Laboratories International, Inc.
Discovery Life Sciences, Inc.
Precision for Medicine, Inc.
StemExpress, LLC
Lonza Group AG
Caltag Medsystems Limited
Stemcell Technologies
Trina Bioreactives AG
AcceGen
First Choice Bio LLC
결론과 추천 사항
LSH
영문 목차
영문목차
Global Leukapheresis Market size was valued at USD 66.3 million in 2022 and is poised to grow from USD 71.87 million in 2023 to USD 137.02 million by 2031, growing at a CAGR of 8.40% during the forecast period (2024-2031).
The global leukapheresis market is experiencing significant growth, driven by rising incidences of hematologic disorders and autoimmune diseases. This process of selectively separating white blood cells plays a crucial role in treating conditions like leukemia and autoimmune disorders while advancing diagnostic methods. Technological innovations in leukapheresis systems have improved procedure efficacy and safety, enhancing their appeal as a reliable therapeutic option. However, market growth could be hindered by limited awareness and high costs associated with the necessary equipment and trained personnel. Opportunities abound, especially in the intersection of leukapheresis and personalized medicine, as well as cell-based therapies like CAR T-cell treatment. As healthcare infrastructure develops, investment in research and cost-effective solutions could further expand this vital market sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Leukapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Leukapheresis Market Segmental Analysis
Global Leukapheresis Market is segmented by Type, Application, End User, and region. Based on Type, the market is segmented into Disposables, Devices. Based on Application, the market is segmented into Research Applications, Therapeutic Applications. Based on End User, the market is segmented into Blood component providers & blood centers, Academic & research institutes, Pharmaceutical & biotechnology companies, Hospitals & transfusion centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Leukapheresis Market
The global leukapheresis market is primarily driven by the growing prevalence of hematologic disorders, including leukemia and lymphoma. As the incidence of these conditions continues to rise, the demand for effective treatment options becomes increasingly critical. Leukapheresis is instrumental in managing elevated white blood cell counts associated with these disorders, as it facilitates the rapid removal of leukemic cells from the bloodstream. This procedure not only alleviates symptoms but also helps in preparing patients for further therapeutic interventions. Consequently, the increasing recognition of leukapheresis as a vital treatment option significantly fuels market growth in this sector.
Restraints in the Global Leukapheresis Market
The global leukapheresis market faces several challenges that may impede its growth. A significant factor is the limited awareness of both healthcare providers and patients regarding the advantages of leukapheresis procedures. This lack of knowledge highlights the need for comprehensive educational initiatives aimed at fostering a better understanding of this therapeutic option. Additionally, the high expenses associated with leukapheresis devices and consumables pose another barrier, especially in resource-limited environments. Moreover, the requirement for skilled healthcare professionals to conduct these procedures further complicates accessibility, underscoring the necessity for targeted strategies to improve awareness and affordability in the market.
Market Trends of the Global Leukapheresis Market
The global leukapheresis market is witnessing a significant trend towards integration with cell-based therapies, particularly chimeric antigen receptor (CAR) T-cell therapy. This approach allows for the efficient collection and genetic modification of patient-derived white blood cells, which are essential for developing effective treatments against cancer. As healthcare providers increasingly recognize the potential of combining leukapheresis with advanced cell therapies, demand for leukapheresis technologies is expected to surge. This synergy not only enhances treatment efficacy but also drives innovation in leukapheresis procedures, positioning it as a cornerstone in the evolving landscape of personalized cancer care.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Driver & Opportunities
Restraints & Challenges
Porters Analysis & Impact
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies
Global Leukapheresis Market Size by Type & CAGR (2024-2031)
Market Overview
Disposables
Devices
Centrifugal Devices
Membrane Separators
Global Leukapheresis Market Size by Application & CAGR (2024-2031)
Market Overview
Research Applications
Therapeutic Applications
Global Leukapheresis Market Size by End User & CAGR (2024-2031)
Market Overview
Blood component providers & blood centers
Academic & research institutes
Pharmaceutical & biotechnology companies
Hospitals & transfusion centers
Global Leukapheresis Market Size & CAGR (2024-2031)
North America (Type, Application, End User)
US
Canada
Europe (Type, Application, End User)
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific (Type, Application, End User)
China
India
Japan
South Korea
Rest of Asia Pacific
Latin America (Type, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Type, Application, End User)
